A practical reference on pentadecapeptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-02-20. Anything still debated is marked as such rather than presented as settled.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Computed for the free peptide |
| Monoisotopic mass | Approximately 1419 Da | Reported values shift with counterion and hydration |
| Residue count | 15 amino acids | Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Fragment of human gastric juice protein | First described in early 1990s research reports |
| Common synonyms | BPC 157; PL 14736; bepecin | Naming varies across papers and catalogues |
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
=== Record label signings and dispute over Kendrick Lamar's lyrics === Sometime after deciding to return, Clipse signed to Def Jam Recordings, which had already been Pusha T's label as a solo artist from when GOOD Music was a Def Jam imprint. Let God Sort Em Out was delayed significantly from a planned 2024 release when Def Jam and its parent company Universal Music Group wanted a guest verse by Kendrick Lamar to be censored or removed, initially reported to be because both he and Pusha T have had feuds with Drake, leading to the exchanging of diss tracks in 2018 and 2024, respectively; Universal were said to be uncomfortable with the "optics" of the situation, and Drake's feud with Lamar would eventually result in a lawsuit by Drake against them. It was later clarified that the official reason was use of the phrase "Trump card" in the lyrics and concerns of conflict with United States President Donald Trump, although Pusha T personally believed that this was merely an excuse, as he claimed to have been censored by Def Jam numerous times since 2018 over lyrics that could be perceived as Drake disses. The signing wasn't announced until October 2024. Journalist Elias Leight wrote that the duo was already signed as of "early" 2024. Music industry executive Brian Zisook publicly claimed that Clipse was already under Def Jam c. June 2023. Clipse refused to censor or remove the verse.
=== Video games === Half-Life (1998) Half-Life 2 (2004) Half-Life 2: Episode One (2006) Half-Life 2: Episode Two (2007) Portal (2007) Counter-Strike: Global Offensive (additional music, 2015) Vanishing Realms: Rite of Steel (2016-2019)
30 July – The Parliamentary Commissioner for Standards launches an investigation into Nigel Farage over a potential breach of parliamentary rules over financial interests. Former Downing Street Chief of Staff Sue Gray is appointed to the board of governors of Queen's University Belfast. Adam Holloway, the former Conservative MP for Gravesham, defects to Reform UK. 31 July – James Orr, chairman of the pro-Reform UK think tank, the Centre for a Better Britain, tells the Today programme an incoming Reform government would have to do some "very unpopular" things in its first 100 days in office and force "nasty cough medicine down the country's throat" but that if "Reform ends up governing the country, we should all want them to succeed".
In 18th-century Europe, it is estimated that 400,000 people died from the disease per year, and that one-third of all cases of blindness were due to smallpox. Smallpox is estimated to have killed up to 300 million people in the 20th century and around 500 million people in the last 100 years of its existence. Earlier deaths included multiple European monarchs. As recently as 1967, 15 million cases occurred a year. Inoculation for smallpox appears to have started in China around the 1500s. Europe adopted this practice from Asia in the first half of the 18th century. In 1796, Edward Jenner introduced the modern smallpox vaccine. In 1967, the World Health Organization intensified efforts to eliminate the disease. Smallpox is one of two infectious diseases to have been eradicated, the other being rinderpest (a disease of even-toed ungulates) in 2011. The term "smallpox" was first used in England in the 16th century to distinguish the disease from syphilis, which was then known as the "great pox". Other historical names for the disease include pox, speckled monster, and red plague.
Sources: en.wikipedia.org
=== Reproducibility === While the underlying mathematical model is publicly known, the dataset which is used to calculate the JIF is not publicly available. This prompted criticism: "Just as scientists would not accept the findings in a scientific paper without seeing the primary data, so should they not rely on Thomson Scientific's impact factor, which is based on hidden data". However, a 2019 article demonstrated that "with access to the data and careful cleaning, the JIF can be reproduced", although this required much labour to achieve. A 2020 research paper went further. It indicated that by querying open access or partly open-access databases, like Google Scholar, ResearchGate, and Scopus, it is possible to calculate approximate impact factors without the need to purchase Web of Science / JCR.
The indictment against Duterte, which was made public on September 22, 2025, accused him of involvement in the murders of 76 people between 2013 and 2018. Fifty-seven of the killings took place during his presidency, and the other 19 occurred during his third term as mayor of Davao City. On October 10, 2025, the ICC rejected a request from Duterte to be released from detention, arguing that he posed a risk of fleeing and would not be willing to return for trial, as well as presenting concerns about potential witness intimidation if he were granted freedom. On January 26, 2026, the ICC declared Duterte fit for trial, overruling efforts by his lawyers to have the charges dismissed on health grounds. Duterte waived his right to appear at any proceedings, with his lawyer Nicholas Kaufman stating that he was not mentally fit to follow the hearing. On April 23, 2026, the Pre-Trial Chamber of the ICC committed Duterte to trial. In May 2026, the ICC Pre-Trial Chamber I denied Duterte's appeal to dismiss the charges. That same month the Trial Chamber III of the ICC set the opening statements in Duterte's trial to begin on November 30, 2026. On September 3, 2026, his defense asked the ICC to verify digital evidence presented by the prosecution, saying that much of the material against Duterte had been taken from open-source and user-generated content from the internet.
Under the partitioning powers, economic diversification and progress, including large-scale industrialisation, were introduced in the traditionally agrarian Polish lands, but this development turned out to be very uneven. Advanced agriculture was practiced in the Prussian Partition, except for Upper Silesia, where the coal-mining industry created a large labor force. The densest network of railroads was built in German-ruled western Poland. In Russian Congress Poland, a striking growth of industry, railways and towns took place, all against the background of an extensive, but less productive agriculture. The industrial initiative, capital and know-how were provided largely by entrepreneurs who were not ethnic Poles. Warsaw (a metallurgical center) and Łódź (a textiles center) grew rapidly, as did the total proportion of urban population, making the region the most economically advanced in the Russian Empire (industrial production exceeded agricultural production there by 1909). The coming of the railways spurred some industrial growth even in the vast Russian Partition territories outside of Congress Poland. The Austrian Partition was rural and poor, except for the industrialized Cieszyn Silesia area. Galician economic expansion after 1890 included oil extraction and resulted in the growth of Lemberg (Lwów, Lviv) and Kraków. Economic and social changes involving land reform and industrialization, combined with the effects of foreign domination, altered the centuries-old social structure of Polish society.
== Use and toxicity == The European species did not enter into the herbalists' pharmacopeia. In the American Old West, the Western white clematis, Clematis ligusticifolia, was called pepper vine by early travelers and pioneers, who took a tip from Spanish colonials and used seeds and the acrid leaves of yerba de chivato as a pepper substitute. The entire genus contains essential oils and compounds which are extremely irritating to the skin and mucous membranes. Unlike black pepper or Capsicum, however, the compounds in clematis cause internal bleeding of the digestive tract if ingested in large amounts. C. ligusticifolia is essentially toxic. When pruning them, it is a good idea to wear gloves. Despite its toxicity, Native Americans used very small amounts of clematis as an effective treatment for migraine headaches and nervous disorders. It was also used as an effective treatment of skin infections. Clematis is also a constituent of Bach's Rescue Remedy. Leaf extracts from two Ethiopian species (Clematis longicauda steud ex A. Rich. and Clematis burgensis Engl.) are used locally to treat ear disorders and eczema. Phytochemical screening of the extracts from both of these species showed antibacterial and antifungal activity. The extracts of these plants also possess wound healing and anti-inflammatory activities which could also be attributed to the phytoconstituents. Clematis has been listed as one of the 38 plants used to prepare Bach flower remedies, a kind of alternative medicine promoted for its effect on health.
=== Dimension-5 proton decay operators === Also dimension-5 operators are possible in supersymmetric models, even after the introduction of R-parity, for instance where a heavy color-triplet Higgs exchange (represented by the internal Higgsino lines
Sources: en.wikipedia.org
=== Intramuscular injection === Intramuscular injections are injections into muscle, for instance the gluteal or deltoid muscle. Estradiol and estradiol esters can be administered in a variety of forms by intramuscular injection. Aqueous solutions of estradiol and estradiol esters by intramuscular injection have a rapid onset and duration analogously to but slightly more delayed than intravenous injection. However, intramuscular injections of oil solutions, crystalline aqueous suspensions, and emulsions of estradiol and estradiol esters, as well as solutions and suspensions of estradiol polymers and estradiol microspheres, act as long-lasting depot injections. Estradiol esters, including but not limited to estradiol benzoate, estradiol valerate, estradiol cypionate, estradiol enanthate, and estradiol undecylate, are inactive prodrugs of estradiol that are converted into estradiol in the body. The aforementioned estradiol esters are fatty acid esters and are more lipophilic (fat-soluble) than estradiol. More lipophilic compounds are absorbed more slowly from the injection site when given by depot intramuscular injection (as oil solutions, aqueous suspensions, and emulsions), and hence more lipophilic estradiol esters have longer durations than free estradiol or less lipophilic estradiol esters via this route. Polyestradiol phosphate is a polymer of the hydrophilic (water-soluble) estradiol ester estradiol phosphate which circulates in the blood but is metabolized into estradiol very slowly.
== References == This article was submitted to WikiJournal of Medicine for external academic peer review in 2022 (reviewer reports). The updated content was reintegrated into the Wikipedia page under a CC-BY-SA-3.0 license (2023). The version of record as reviewed is: Maxim Masiutin, Maneesh Yadav, et al. (2023). "Alternative androgen pathways" (PDF). WikiJournal of Medicine. 10 (1): 3. doi:10.15347/wjm/2023.003. Wikidata Q100737840.
GGT is a microsomal enzyme found in hepatocytes, biliary epithelial cells, renal tubules, pancreas, and intestines. It helps in glutathione metabolism by transporting peptides across the cell membrane. Much like ALP, GGT measurements are usually elevated if cholestasis is present. In acute viral hepatitis, the GGT levels can peak at 2nd and 3rd week of illness, and remained elevated at 6 weeks of illness. GGT is also elevated in 30% of the hepatitis C patients. GGT can increase by 10 times in alcoholism. GGT can increase by 2 to 3 times in 50% of the patients with non-alcoholic liver disease. When GGT levels are elevated, the triglyceride level is elevated also. With insulin treatment, the GGT level can reduce. Other causes of elevated GGT are: diabetes mellitus, acute pancreatitis, myocardial infarction, anorexia nervosa, Guillain–Barré syndrome, hyperthyroidism, obesity and myotonic dystrophy. In pregnancy conditions GGT activity is reduced in 2nd and 3rd trimesters. In hyperemesis gravidarum, GGT level value can reach 45 IU/L, 17 IU/L in pre-eclampsia, and 35 IU/L in HELPP syndrome.
Ceramic petrography (or ceramic petrology) is a laboratory-based scientific archaeological technique that examines the mineralogical and microstructural composition of ceramics and other inorganic materials under the polarised light microscope in order to interpret aspects of the provenance and technology of artefacts. The process of ceramic petrography involves careful sample preparation. Small sections of the ceramic material are carefully ground down to a thickness of approximately 0.03 mm and then mounted on glass slides. These thin sections allow for the examination of the internal structure of the ceramics and facilitate the identification of mineral phases, crystalline structures, and textural features. The methodology of ceramic petrography draws upon principles from various fields, including optical mineralogy, thin section petrography, and soil micromorphology
Sources: en.wikipedia.org
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.
No medicines regulator in the United States or the European Union has approved BPC-157 as a therapeutic product. Presenting it as a drug or as a dietary supplement ingredient would generally not match its regulatory status. Availability as a research chemical does not imply clinical approval.
Published reports rest largely on animal models and cell culture rather than controlled human trials. Review articles describe the proposed mechanisms as incompletely understood. Conclusions about effects in humans therefore remain tentative.
Lyophilised peptide powders are generally kept frozen or refrigerated, dry, and protected from light. Sealed vials limit moisture uptake and slow hydrolysis. Such guidance comes from general peptide chemistry rather than from stability studies specific to every product.